Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Kuznetsov 2011 Biochim Biophys Acta

From Bioblast
Publications in the MiPMap
Kuznetsov AV, Margreiter R, Amberger A, Saks V, Grimm M (2011) Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death. Biochim Biophys Acta 1813:1144-52.

Β» PMID:21406203

Kuznetsov AV, Margreiter R, Amberger A, Saks V, Grimm M (2011) Biochim Biophys Acta

Abstract: Mitochondria play central roles in cell life as a source of energy and in cell death by inducing apoptosis. Many important functions of mitochondria change in cancer, and these organelles can be a target of chemotherapy. The widely used anticancer drug doxorubicin (DOX) causes cell death, inhibition of cell cycle/proliferation and mitochondrial impairment. However, the mechanism of such impairment is not completely understood. In our study we used confocal and two-photon fluorescence imaging together with enzymatic and respirometric analysis to study short- and long-term effects of doxorubicin on mitochondria in various human carcinoma cells. We show that short-term (<30 min) effects include i) rapid changes in mitochondrial redox potentials towards a more oxidized state (flavoproteins and NADH), ii) mitochondrial depolarization, iii) elevated matrix calcium levels, and iv) mitochondrial ROS production, demonstrating a complex pattern of mitochondrial alterations. Significant inhibition of mitochondrial endogenous and uncoupled respiration, ATP depletion and changes in the activities of marker enzymes were observed after 48 h of DOX treatment (long-term effects) associated with cell cycle arrest and death. β€’ Keywords: confocal imaging, doxorubicin, mitochondria, mitochondrial function, redox state, reactive oxygen species (ROS)

β€’ O2k-Network Lab: FR_Grenoble_Saks VA


Stress:Cell death, Oxidative stress;RONS  Organism: Human  Tissue;cell: Endothelial;epithelial;mesothelial cell  Preparation: Intact cells 

HRR: Oxygraph-2k 

colon cancer, breast cancer